Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Organicell Regenerative Medicine, Inc. | bpsr_10q.htm |
| EX-31.1 - CERTIFICATION - Organicell Regenerative Medicine, Inc. | bpsr_ex31.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Albert Mitrani, President, Chief Executive Officer, Treasurer and a director of Biotech Products Services and Research, Inc. (the "Company"), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of the Company for the quarter ended July 31, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: October 29, 2015 | By: | /s/ Albert Mitrani |
|
| Name: | Albert Mitrani |
|
| Title: | President, Chief Executive Officer, Treasurer and a director (Principal Executive, Financial and Accounting Officer) |
|
This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.